glp-1 candidates Weight Loss Candidates: Clinical Eligibility & Biomarkers – PlexusDx Who Qualifies for Tirzepatide Medical
Description
By Trace Curry, MD, FASMBS Medical Director, JourneyLite Weight Loss Surgery vs
Participants who had not lost at least 5% of their starting body weight by week 12 rarely achieved robust results by week 48
( PMID: 35223310
Taken together, the data support a cautious yet balanced interpretation
